Continuing the Conversation: Exploring B-cell Maturation Antigen-Targeted Therapies and Managed Care Considerations for Patients With Multiple Myeloma | PTCE Pharmacy Connect

Educational Objectives Discuss the differing classes of B-cell maturation antigen-directed therapy for multiple myeloma Study the economic burden of multiple myeloma and cost-effective treatment strategies for B-cell maturation antigen-directed treatments Faculty: Joseph A. Kalis, PharmD, BCOP Ambulatory Oncology Pharmacist UCHealth Hematology/Oncology Colorado Springs, Colorado   Scott A. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Director, Pharmacy Cancer Care Department of Pharmacy Mayo Clinic   Assistant Professor of Pharmacy Mayo Clinic College of Medicine and Sciences Rochester, Minnesota   Joseph A. Kalis, PharmD, BCOP, has the following financial relationships with commercial interests to disclose:Speakers Bureau: Oncopeptides, GSK Scott A. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA, has the following financial relationships with commercial interests to disclose:Grant/Research Support: AstraZeneza, Janssen Consultant: BeiGene Speakers Bureau: Pfizer   Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-359-H01-P. The activity is available for CE credit through July 29, 2023.   This educational activity is supported by an educational grant from GlaxoSmithKline.